Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.

@article{JoinLambert2011EfficacyOR,
  title={Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.},
  author={Olivier F. Join-Lambert and H{\'e}l{\`e}ne Coignard and Jean-Philippe Jais and H{\'e}l{\`e}ne Guet-Revillet and Sylvain Poir{\'e}e and Sylvie Fraitag and Vincent Jullien and Florence Ribadeau-Dumas and Jacques Th{\'e}ze and Anne-Sophie Le Guern and Sylvie Behillil and Anne Lefl{\`e}che and Patrick Berche and Paul Henri Consigny and Olivier Lortholary and Xavier Nassif and Aude Nassif},
  journal={Dermatology},
  year={2011},
  volume={222 1},
  pages={49-58}
}
BACKGROUND Antibiotics have been shown to improve hidradenitis suppurativa (HS) patients but complete remission is rare using these treatments. OBJECTIVE To assess the efficacy and safety of a combination of oral rifampin, moxifloxacin and metronidazole in long-lasting refractory HS. METHODS We retrospectively studied 28 consecutive HS patients… CONTINUE READING